Secondary prevention in thrombotic antiphospholipid syndrome

被引：11

作者：

Pengo, V. ^{[1
]}

Denas, G. ^{[1
]}

Banzato, A. ^{[1
]}

Bison, E. ^{[1
]}

Bracco, A. ^{[1
]}

Facchinetti, M. ^{[2
]}

Hoxha, A. ^{[2
]}

Ruffatti, A. ^{[2
]}

机构：

[1] Univ Padua, Thrombosis Ctr, Dept Cardiac Thorac & Vasc Sci, I-35128 Padua, Italy

[2] Univ Padua, Rheumatol Unit, Dept Med, I-35128 Padua, Italy

来源：

LUPUS | 2012年 / 21卷 / 07期

关键词：

antiphospholipid; prevention; drugs; thrombosis; RECURRENT THROMBOSIS; THERAPY; INTENSITY; WARFARIN; RISK;

D O I：

10.1177/0961203312444773

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Secondary prevention of venous thromboembolism in antiphospholipid syndrome (APS) is usually made using vitamin K antagonists (VKAs) to maintain an international normalized ratio (INR) between 2.0 and 3.0. The optimal intensity of anticoagulation was determined in two prospective randomized controlled trials, both excluding the benefit of more intense anticoagulation. The same regimen is also recommended in patients with APS and arterial thromboembolism as aspirin does not appear to protect against recurrences. The duration of treatment is usually indefinite because of a substantial risk of recurrence. Lupus (2012) 21, 734-735.

引用

页码：734 / 735

页数：2

共 50 条

[31] New oral anticoagulants in thrombotic antiphospholipid syndrome
Chighizola, C. B.
Moia, M.
Meroni, P. L.
LUPUS, 2014, 23 (12) : 1279 - 1282
[32] Treatment of thrombotic antiphospholipid syndrome in adults and children
Madison, Jacqueline A.
Duarte-Garcia, Ali
Zuo, Yu
Knight, Jason S.
CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (03) : 215 - 227
[33] A PRIMARY THROMBOTIC SYNDROME - ABSENCE OF ANTIPHOSPHOLIPID ANTIBODIES
SABBAGA, J
NETO, JF
CHADDAD, R
CECCONELLO, I
DEOLIVEIRA, RM
CLINICAL RHEUMATOLOGY, 1991, 10 (01) : 81 - 83
[34] PREMATURE ATHEROSCLEROSIS IN THROMBOTIC PRIMARY ANTIPHOSPHOLIPID SYNDROME
Ames, Paul R.
Antinolfi, Iole
Scenna, Giovanna
Gaeta, Giovanni
Margarita, Annamaria
Margaglione, Maurizio
RHEUMATOLOGY, 2009, 48 : I45 - I45
[35] Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies
Wolfgang Miesbach
Inge Scharrer
Ronald Asherson
Clinical Rheumatology, 2006, 25 : 840 - 844
[36] THROMBOTIC CEREBRAL ARTERIOPATHY IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME
HUGHSON, MD
MCCARTY, GA
SHOLER, CM
BRUMBACK, RA
MODERN PATHOLOGY, 1993, 6 (06) : 644 - 653
[37] Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome
Belizna, Cristina
AUTOIMMUNITY REVIEWS, 2015, 14 (04) : 358 - 362
[38] Antiphospholipid syndrome and tissue factor:: a thrombotic couple
López-Pedrera, C
Buendía, P
Aguirre, MA
Velasco, F
Cuadrado, MJ
LUPUS, 2006, 15 (03) : 161 - 166
[39] Thrombotic manifestations of the antiphospholipid syndrome in patients with malignancies
Miesbach, Wolfgang
Scharrer, Inge
Asherson, Ronald
CLINICAL RHEUMATOLOGY, 2006, 25 (06) : 840 - 844
[40] Thrombotic microangiopathy associated with primary antiphospholipid syndrome
Queralt, C
Vidal, N
MEDICINA CLINICA, 2000, 114 (16): : 631 - 636

← 1 2 3 4 5 →